Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

BACKGROUND: Assessment of measurable residual disease (MRD) is rapidly transforming the therapeutic and prognostic landscape of a wide range of hematological malignancies. Its prognostic value in acute lymphoblastic leukemia (ALL) has been established and MRD measured at the end of induction is incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavlů, Jiří, Labopin, Myriam, Niittyvuopio, Riitta, Socié, Gerard, Yakoub-Agha, Ibrahim, Wu, Depei, Remenyi, Peter, Passweg, Jakob, Beelen, Dietrich W., Aljurf, Mahmoud, Kröger, Nicolaus, Labussière-Wallet, Hélène, Perić, Zinaida, Giebel, Sebastian, Nagler, Arnon, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813121/
https://www.ncbi.nlm.nih.gov/pubmed/31647022
http://dx.doi.org/10.1186/s13045-019-0790-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813121/
https://www.ncbi.nlm.nih.gov/pubmed/31647022
http://dx.doi.org/10.1186/s13045-019-0790-x

Ejemplares similares